盈康生命

300143.SZ

Wind Industry: 医疗保健 > 医疗设备与服务 > 医疗保健提供商与服务 > 保健护理服务

公司成立于1998年，于2010年先的肿瘤关键设备综合服务商和肿瘤医疗服务运营商。12月在深圳证券交易所创业板上市。公司秉承“天下人”的使命愿景，积极融入国家科技创新、健康等发展战略，已经成长为国内领先的医疗服务运营商。公司采用医院+生态+平台的经营模式，一方面，聚焦区域医疗中心建设，以患者体验为中心，以学科差异化发展为驱动，持续提升医疗服务竞争力，另一方面推进数智化转型，通过医疗+AI重塑医疗生态和用户体验，构筑全周期健康管理服务能力。在医疗器械板块，公司围绕肿瘤预/诊/治/康关键场景、关键设备的研发、创新和服务开展布局，产品属从肿瘤治疗领域向前后延伸，主要覆盖放射治疗、生命支持、影像增强、慢病治疗四大应用场景。公司产品已应用于北京协和医院、四川大学华西医院、中山大学附属第一医院等全国800多家三甲医院和国内3,000多家各级医院，出口美国、欧洲等全球90多个国家和地区。

ESG Score Industry Ranking:
1 / 118 (医疗保健提供商与服务)

ESG Rating Distribution(医疗保健提供商与服务)

AAA

2.54%

17.80%

23.73%

BBB

31.36%

17.80%

1.69%

CCC

Trend of Rating

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：8.89Updated on 2026-10-29

08.8910

Management & Practices Score：5.89Updated on 2026-09-16

05.897

Controversies Score：3.00Updated on 2026-10-29

03.003

ESG Score Comparison

Indicator	Company Score	Industry Average	Weight
Environmental	7.09	3.34	5.17%
Social	8.82	3.84	67.23%
Governance	7.68	5.25	27.59%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB

More Details

Peer Comparison(118 companies in the industry) ?

Ranking	Code	Security Name	ESG Rating	ESG Score	Controversies Score	Management & Practices Score	Environmental	Social	Governance
1	300143.SZ	盈康生命	AA	8.89	3.00	5.89	7.09	8.82	7.68
2	2325.HK	云康集团	AA	8.19	2.99	5.19	5.36	7.87	6.73
3	300015.SZ	爱尔眼科	AA	8.17	2.99	5.18	6.28	7.34	7.75
4	9860.HK	艾迪康控股	A	7.97	3.00	4.97	3.99	7.26	7.29
5	000963.SZ	华东医药	A	7.94	3.00	4.94	5.39	7.03	7.45
6	000950.SZ	重药控股	A	7.84	2.99	4.85	5.54	7.03	6.95
7	603882.SH	金域医学	A	7.83	2.94	4.89	4.05	7.26	6.89
8	301103.SZ	何氏眼科	A	7.82	2.98	4.84	4.10	7.35	6.40
9	600056.SH	中国医药	A	7.63	2.99	4.63	4.83	6.45	7.38
10	2666.HK	环球医疗	A	7.61	3.00	4.61	3.78	6.81	6.57